OTC Pharmaceuticals in Indonesia

OTC Pharmaceuticals in Indonesia

Code: ML-OHME3771 | Published: Sep-2015 | Pages: 37 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

OTC Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Indonesia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2014 annual average exchange rates.

- The Indonesian OTC pharmaceuticals market had total revenues of $1.5bn in 2014, representing a compound annual growth rate (CAGR) of 3.9% between 2010 and 2014.

- The traditional medicines segment was the markets most lucrative in 2014, with total revenues of $0.4bn, equivalent to 29.7% of the markets overall value.

- In 2014, Indonesia launched ambitious healthcare reforms known as Jaminan Kesehatan Nasional (JKN), aimed at universal coverage of the worlds fourth most populous country by 2019.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Indonesia

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Indonesia

Leading company profiles reveal details of key otc pharmaceuticals market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia otc pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Indonesia economy

Reasons To Buy
What was the size of the Indonesia otc pharmaceuticals market by value in 2014?

What will be the size of the Indonesia otc pharmaceuticals market in 2019?

What factors are affecting the strength of competition in the Indonesia otc pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Indonesias otc pharmaceuticals market?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market share 11
Market distribution 12
Market Outlook 13
Market value forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Bayer AG 20
Darya-Varia Laboratoria Tbk 24
Johnson and Johnson 27
PT Sanbe Farma 31
Macroeconomic Indicators 32
Country Data 32
Methodology 34
Industry associations 35
Related MarketLine research 35
Appendix 36
About MarketLine 36
LIST OF TABLES
Table 1: Indonesia OTC pharmaceuticals market value: $ million, 2010-14 8
Table 2: Indonesia OTC pharmaceuticals market category segmentation: $ million, 2014 9
Table 3: Indonesia OTC pharmaceuticals market geography segmentation: $ million, 2014 10
Table 4: Indonesia OTC pharmaceuticals market share: % share, by value, 2014 11
Table 5: Indonesia OTC pharmaceuticals market distribution: % share, by value, 2014 12
Table 6: Indonesia OTC pharmaceuticals market value forecast: $ million, 2014-19 13
Table 7: Bayer AG: key facts 20
Table 8: Bayer AG: key financials ($) 21
Table 9: Bayer AG: key financials (Euro) 22
Table 10: Bayer AG: key financial ratios 22
Table 11: Darya-Varia Laboratoria Tbk: key facts 24
Table 12: Darya-Varia Laboratoria Tbk: key financials ($) 24
Table 13: Darya-Varia Laboratoria Tbk: key financials (IDR) 25
Table 14: Darya-Varia Laboratoria Tbk: key financial ratios 25
Table 15: Johnson and Johnson: key facts 27
Table 16: Johnson and Johnson: key financials ($) 28
Table 17: Johnson and Johnson: key financial ratios 29
Table 18: PT Sanbe Farma: key facts 31
Table 19: Indonesia size of population (million), 2010-14 32
Table 20: Indonesia gdp (constant 2005 prices, $ billion), 2010-14 32
Table 21: Indonesia gdp (current prices, $ billion), 2010-14 32
Table 22: Indonesia inflation, 2010-14 33
Table 23: Indonesia consumer price index (absolute), 2010-14 33
Table 24: Indonesia exchange rate, 2010-14 33
LIST OF FIGURES
Figure 1: Indonesia OTC pharmaceuticals market value: $ million, 2010-14 8
Figure 2: Indonesia OTC pharmaceuticals market category segmentation: % share, by value, 2014 9
Figure 3: Indonesia OTC pharmaceuticals market geography segmentation: % share, by value, 2014 10
Figure 4: Indonesia OTC pharmaceuticals market share: % share, by value, 2014 11
Figure 5: Indonesia OTC pharmaceuticals market distribution: % share, by value, 2014 12
Figure 6: Indonesia OTC pharmaceuticals market value forecast: $ million, 2014-19 13
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Indonesia, 2014 14
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Indonesia, 2014 15
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Indonesia, 2014 16
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Indonesia, 2014 17
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Indonesia, 2014 18
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Indonesia, 2014 19
Figure 13: Bayer AG: revenues and profitability 22
Figure 14: Bayer AG: assets and liabilities 23
Figure 15: Darya-Varia Laboratoria Tbk: revenues and profitability 25
Figure 16: Darya-Varia Laboratoria Tbk: assets and liabilities 26
Figure 17: Johnson and Johnson: revenues and profitability 29
Bayer AG; Darya-Varia Laboratoria Tbk; Johnson and Johnson; PT Sanbe Farma

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
MarketLine